Efficacy of SL-701 in adult patients with glioblastoma multiforme.
Phase of Trial: Phase II
Latest Information Update: 26 Apr 2018
At a glance
- Drugs SL 701 (Primary)
- Indications Glioblastoma
- Focus Therapeutic Use
- 26 Apr 2018 According to a Stemline Therapeutics media release, data from this trial will be presented at the 54th Annual Meeting of the American Society of Clinical Oncology (ASCO) (Jun 2018).
- 08 Mar 2018 Status changed from active, no longer recruiting to completed, according to a Stemline Therapeutics media release.
- 10 May 2017 According to a Stemline Therapeutics media release, updates from this trial are expected in 2018.